• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Consumer Defensive·AQPW
Share

Golden Ally Lifetech Group, Inc. Stocks

$ 0Last Updated 23.10.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

$ 740856

$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Golden Ally Lifetech Group, Inc., a company in its developmental stage, concentrates on innovating across advanced technologies, energy solutions, and medical equipment. Within the bioscience and sports medicine fields, it is actively developing items like Sterilal self-sanitizing devices, PASS smart denture mouth guards, portable heart attack detection units, and melanoma screening systems. Additionally, the company provides the InCharge magnetic battery device for energy, and is making progress on graphene-based de-icing applications for the aviation industry. Founded in 2003 and headquartered in Austin, Texas, the firm was formerly known as Signet International Holdings, Inc. until it rebranded in July 2022.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

29.10.2026 01:34

Microsoft Beat Forecasts for Cloud Revenue

29.10.2026 01:17

"The Moment of Truth": Alphabet Shares Plunge 10% After Disappointing Earnings Report

29.10.2026 01:07

The U.S. Federal Reserve will reduce the number of interest rate meetings starting in 2027

29.10.2026 00:35

Is this the end of the “Magnificent Seven”? Big Tech stocks have diverged in their performance. Which ones should you choose?

29.10.2026 00:10

Oracle surprised the market with its cash flow forecast. Its shares soared 12%.

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026